Company News
Tuesday preview: US CPI, Spring statement in focus
All eyes will be on the latest US consumer price data and the Chancellor's Spring statement on Tuesday.
Salt Lake Potash inks MOU with Australian gold miner
AIM-quoted mineral exploration company Salt Lake Potash has signed a memorandum of understanding with gold mining firm Blackham Resources on the potential development of a potash sulphate project in Australia.
Hutchison seeks approval for cancer drug after trial success
Cancer drug development company Hutchison China Meditech plans to gain approval for its fruquintinib drug as China’s first Tyrosine-Kinase inhibitor (TKI), the company said on Monday.
President Energy to reactivate Argentine field after encouraging tests
President Energy announced the results of recent reactivation testing of gas wells in Argentina on Monday, noting a live gas field with potentially commercial gas flows.
African Battery Metals eyes cobalt prospects at Kisinka licence
African Battery Metals (ABM) announced on Monday that it will increase focus on its cobalt projects at its Kisinka licence in the Democratic Republic of Congo (DRC).
Pennant International profits hurt by CEO termination payout
Technical training solutions company Pennant International reported a decrease in profits for 2017 on Monday, despite achieving revenue growth over the year.
Ariana Resources to outstrip feasibility plan at Turkish gold mine
Ariana Resources announced on Monday that it expects its Kiziltepe project in Turkey to produce 20,000 ounces of gold in 2018, an increase of 47% over 2017.
Multi-billion pound E.ON-RWE asset swap may scupper SSE-Innogy tie-up
Shares of E. ON and RWE were catapulted higher by news of a multi-billion pound asset swap aimed at fending off the entry of European rivals into their main market.
Universe installs next-generation POS at 70th Rontec forecourt
Point-of-sale, payment and online loyalty systems developer and supplier Universe Group has installed its next-generation point-of-sale, back office and head office solution in its 70th site for petrol forecourt operator Rontec, it announced on Monday.
Melrose sweetens GKN bid to £8.1bn
Turnaround specialist Melrose Industries has upped its offer for engineer GKN to 467p per share, or £8. 1bn, from £7. 4bn.
FreeAgent bolsters sales focus with appointment of Nick Longden
Cloud-based software-as-a-service (SaaS) accounting software provider FreeAgent Holdings announced the appointment of Nick Longden as vice-president of sales on Monday, to help spearhead its growth strategy within its accounting practice division.
Intertek buys Malta-based Aldo Abela Surveys
Product testing, inspection and certification company, Intertek, has acquired Malta-based quality and quantity cargo inspection services provider Aldo Abela Surveys (AAS) for an undisclosed sum.
Physiomics completes Innovate UK oesophageal cancer project
Cancer treatment prediction technology provider Physiomics has successfully completed the Innovate UK grant project announced in January last year, it announced on Monday.
Kromek wins extension to US dirty bomb detection contract
Radiation detection technology company Kromek has been awarded an extension to its high-volume production contract with the Defense Advanced Research Projects Agency (DARPA), an agency of the US Department of Defense, initially awarded in February 2016.
Diurnal losses widen ahead of maiden revenue
Clinical-stage pharmaceutical company Diurnal saw losses widen in the first half of its trading year as costs rose ahead of the launch of its maiden product.
VR Education given warm welcome on AIM arrival
Trading of virtual reality technology company VR Education's shares began in London and Ireland on Monday morning after the firm raised a total of £6m, rising more than 17% on debut.
Biogen to buy Pfizer schizophrenia drug for up to $590m
Biogen has agreed to buy a phase 2b trial-ready schizophrenia treatment from Pfizer for up to $590m.
Boost for GSK as Hikma, Vectura expect 2020 launch for generic Advair
Generic drug-maker Hikma Pharmaceuticals will carry out a clinical trial of its generic version of GlaxoSmithKline's Advair Diskus asthma drug after consultation with the US drug regulator.
Eve Sleep posts wider losses but expects to be profitable in the UK this year
Eve Sleep said on Monday that it's aiming to be profitable in the UK this year, as it reported a widening of its losses in 2017.
Oclaro surges as it agrees $1.8bn buyout with Lumentum
Shares in optical components manufacturer Oclaro surged in pre-market trade on Monday as it agreed to be bought by Lumentum Holdings, a provider of photonics products, for $1. 8bn.